IL-15 dependent induction of IL-18 secretion as a feedback mechanism controlling human MAIT-cell effector functions

European Journal of Immunology

Volumn 45, Issue 8, 2015, Pages 2286-2298

  Sattler, Arne ^a   Dang Heine, Chantip ^a   Reinke, Petra ^a,b   Babel, Nina ^a,c  

^a Berlin Brandenburg Center of Regenerative Therapies (BCRT)   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Cytokines; IL 15; Inflammation; MAIT cells; T cells

Indexed keywords

CD14 ANTIGEN; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 15; INTERLEUKIN 18; PERFORIN; STAT5 PROTEIN; IFNG PROTEIN, HUMAN; IL15 PROTEIN, HUMAN; INTERLEUKIN 18 PROTEIN, HUMAN; LYMPHOCYTE ANTIGEN RECEPTOR;

ARTICLE; CELL ACTIVATION; CELL ACTIVITY; CELL FUNCTION; CELLULAR SECRETION; CYTOKINE PRODUCTION; FEEDBACK SYSTEM; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; MUCOSAL ASSOCIATED INVARIANT T CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; UPREGULATION; CAPPING PHENOMENON; CYTOLOGY; FEMALE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; MUCOSA; PHYSIOLOGY;

FEMALE; HUMANS; IMMUNOLOGIC CAPPING; INTERFERON-GAMMA; INTERLEUKIN-15; INTERLEUKIN-18; LYMPHOCYTE ACTIVATION; MALE; MUCOUS MEMBRANE; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 84938997903     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201445313     Document Type: Article

References (61)

1. Kjer-Nielsen, L., Patel, O., Corbett, A. J., Le Nours, J., Meehan, B., Liu, L., Bhati, M. et al., MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 2012. 491: 717-723.
2. Treiner, E., Duban, L., Bahram, S., Radosavljevic, M., Wanner, V., Tilloy, F., Affaticati, P. et al., Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature 2003. 422: 164-169.
3. Tilloy, F., Treiner, E., Park, S. H., Garcia, C., Lemonnier, F., de la Salle, H., Bendelac, A. et al., An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha/beta T cell subpopulation in mammals. J. Exp. Med. 1999. 189: 1907-1921.
4. Dusseaux, M., Martin, E., Serriari, N., Peguillet, I., Premel, V., Louis, D., Milder, M. et al., Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood 2011. 117: 1250-1259.
5. Le Bourhis, L., Dusseaux, M., Bohineust, A., Bessoles, S., Martin, E., Premel, V., Core, M. et al., MAIT cells detect and efficiently lyse bacterially-infected epithelial cells. PLoS Pathog. 2013. 9: e1003681.
6. Gold, M. C., Cerri, S., Smyk-Pearson, S., Cansler, M. E., Vogt, T. M., Delepine, J., Winata, E. et al., Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol. 2010. 8: e1000407.
7. Gold, M. C., McLaren, J. E., Reistetter, J. A., Smyk-Pearson, S., Ladell, K., Swarbrick, G. M., Yu, Y. Y. et al., MR1-restricted MAIT cells display ligand discrimination and pathogen selectivity through distinct T cell receptor usage. J. Exp. Med. 2014. 211: 1601-1610.
8. Georgel, P., Radosavljevic, M., Macquin, C. and Bahram, S., The non-conventional MHC class I MR1 molecule controls infection by Klebsiella pneumoniae in mice. Mol. Immunol. 2011. 48: 769-775.
9. Meierovics, A., Yankelevich, W. J. and Cowley, S. C., MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection. Proc. Natl. Acad. Sci. USA 2013. 110: E3119-E3128.
10. Chua, W. J., Truscott, S. M., Eickhoff, C. S., Blazevic, A., Hoft, D. F. and Hansen, T. H., Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infection. Infect. Immun. 2012. 80: 3256-3267.
11. Le Bourhis, L., Martin, E., Peguillet, I., Guihot, A., Froux, N., Core, M., Levy, E. et al., Antimicrobial activity of mucosal-associated invariant T cells. Nat. Immunol. 2010. 11: 701-708.
12. Serriari, N. E., Eoche, M., Lamotte, L., Lion, J., Fumery, M., Marcelo, P., Chatelain, D. et al., Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases. Clin. Exp. Immunol. 2014. 176: 266-274.
13. Teunissen, M. B., Yeremenko, N. G., Baeten, D. L., Chielie, S., Spuls, P. I., de Rie, M. A., Lantz, O. et al., The IL-17A-producing CD8 T-cell population in psoriatic lesional skin comprises mucosa-associated invariant T cells and conventional T cells. J. Invest. Dermatol. 2014. 134: 2898-2907
14. Willing, A., Leach, O. A., Ufer, F., Attfield, K. E., Steinbach, K., Kursawe, N., Piedavent, M. et al., CD8(+) MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL-18 serum levels in multiple sclerosis. Eur. J. Immunol. 2014. 44: 3119-3128.
15. Turtle, C. J., Delrow, J., Joslyn, R. C., Swanson, H. M., Basom, R., Tabellini, L., Delaney, C. et al., Innate signals overcome acquired TCR signaling pathway regulation and govern the fate of human CD161(hi) CD8alpha(+) semi-invariant T cells. Blood 2011. 118: 2752-2762.
16. Sattler, A., Wagner, U., Rossol, M., Sieper, J., Wu, P., Krause, A., Schmidt, W. A. et al., Cytokine-induced human IFN-gamma-secreting effector-memory Th cells in chronic autoimmune inflammation. Blood 2009. 113: 1948-1956.
17. Smeltz, R. B., Profound enhancement of the IL-12/IL-18 pathway of IFN-gamma secretion in human CD8+ memory T cell subsets via IL-15. J. Immunol. 2007. 178: 4786-4792.
18. Haque, A., Easton, A., Smith, D., O'Garra, A., Van Rooijen, N., Lertmemongkolchai, G., Titball, R. W. et al., Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection. J. Infect. Dis. 2006. 193: 370-379.
19. Berg, R. E., Crossley, E., Murray, S. and Forman, J., Memory CD8+ T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen. J. Exp. Med. 2003. 198: 1583-1593.
20. Berg, R. E., Crossley, E., Murray, S. and Forman, J., Relative contributions of NK and CD8 T cells to IFN-gamma mediated innate immune protection against Listeria monocytogenes. J. Immunol. 2005. 175: 1751-1757.
21. O'Donnell, H., Pham, O. H., Li, L. X., Atif, S. M., Lee, S. J., Ravesloot, M. M., Stolfi, J. L. et al., Toll-like receptor and inflammasome signals converge to amplify the innate bactericidal capacity of T helper 1 cells. Immunity 2014. 40: 213-224.
22. Brigl, M., Tatituri, R. V., Watts, G. F., Bhowruth, V., Leadbetter, E. A., Barton, N., Cohen, N. R. et al., Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection. J. Exp. Med. 2011. 208: 1163-1177.
23. Le Bourhis, L., Mburu, Y. K. and Lantz, O., MAIT cells, surveyors of a new class of antigen: development and functions. Curr. Opin. Immunol. 2013. 25: 174-180.
24. Ussher, J. E., Bilton, M., Attwod, E., Shadwell, J., Richardson, R., de Lara, C., Mettke, E. et al., CD161++ CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner. Eur. J. Immunol. 2014. 44: 195-203.
25. Huang, S., Gilfillan, S., Cella, M., Miley, M. J., Lantz, O., Lybarger, L., Fremont, D. H. et al., Evidence for MR1 antigen presentation to mucosal-associated invariant T cells. J. Biol. Chem. 2005. 280: 21183-21193.
26. Kurioka, A., Ussher, J. E., Cosgrove, C., Clough, C., Fergusson, J. R., Smith, K., Kang, Y. H. et al., MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets. Mucosal Immunol. 2015. 8: 429-440.
27. Kalina, U., Ballas, K., Koyama, N., Kauschat, D., Miething, C., Arnemann, J., Martin, H. et al., Genomic organization and regulation of the human interleukin-18 gene. Scand. J. Immunol. 2000. 52: 525-530.
28. Leeansyah, E., Ganesh, A., Quigley, M. F., Sonnerborg, A., Andersson, J., Hunt, P. W., Somsouk, M. et al., Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection. Blood 2013. 121: 1124-1135.
29. Cosgrove, C., Ussher, J. E., Rauch, A., Gartner, K., Kurioka, A., Huhn, M. H., Adelmann, K. et al., Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection. Blood 2013. 121: 951-961.
30. Betts, M. R., Brenchley, J. M., Price, D. A., De Rosa, S. C., Douek, D. C., Roederer, M. and Koup, R. A., Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 2003. 281: 65-78.
31. Yang, J., Zhu, H., Murphy, T. L., Ouyang, W. and Murphy, K. M., IL-18-stimulated GADD45 beta required in cytokine-induced, but not TCR-induced, IFN-gamma production. Nat. Immunol. 2001. 2: 157-164.
32. Yu, J. J., Tripp, C. S. and Russell, J. H., Regulation and phenotype of an innate Th1 cell: role of cytokines and the p38 kinase pathway. J. Immunol. 2003. 171: 6112-6118.
33. Verri, W. A., Jr., Cunha, T. M., Ferreira, S. H., Wei, X., Leung, B. P., Fraser, A., McInnes, I. B. et al., IL-15 mediates antigen-induced neutrophil migration by triggering IL-18 production. Eur. J. Immunol. 2007. 37: 3373-3380.
34. Guo, L., Junttila, I. S. and Paul, W. E., Cytokine-induced cytokine production by conventional and innate lymphoid cells. Trends Immunol. 2012. 33: 598-606.
35. Soudja, S. M., Ruiz, A. L., Marie, J. C. and Lauvau, G., Inflammatory monocytes activate memory CD8(+) T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion. Immunity 2012. 37: 549-562.
36. Bastidas, S., Graw, F., Smith, M. Z., Kuster, H., Gunthard, H. F. and Oxenius, A., CD8+ T cells are activated in an antigen-independent manner in HIV-infected individuals. J. Immunol. 2014. 192: 1732-1744.
37. Mattei, F., Schiavoni, G., Belardelli, F. and Tough, D. F., IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J. Immunol. 2001. 167: 1179-1187.
38. Doherty, T. M., Seder, R. A. and Sher, A., Induction and regulation of IL-15 expression in murine macrophages. J. Immunol. 1996. 156: 735-741.
39. Mitani, A., Nishimura, H., Hirose, K., Washizu, J., Kimura, Y., Tanaka, S., Yamamoto, G. et al., Interleukin-15 production at the early stage after oral infection with Listeria monocytogenes in mice. Immunology 1999. 97: 92-99.
40. Kaneko, M., Mizunuma, T., Takimoto, H. and Kumazawa, Y., Development of TCR alpha beta CD8 alpha alpha intestinal intraepithelial lymphocytes is promoted by interleukin-15-producing epithelial cells constitutively stimulated by gram-negative bacteria via TLR4. Biol. Pharm. Bull. 2004. 27: 883-889.
41. Teunissen, M. B., Koomen, C. W., de Waal Malefyt, R., Wierenga, E. A. and Bos, J. D., Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J. Invest. Dermatol. 1998. 111: 645-649.
42. Shiraki, Y., Ishibashi, Y., Hiruma, M., Nishikawa, A. and Ikeda, S., Cytokine secretion profiles of human keratinocytes during Trichophyton tonsurans and Arthroderma benhamiae infections. J. Med. Microbiol. 2006. 55: 1175-1185.
43. Chattopadhyay, P. K., Betts, M. R., Price, D. A., Gostick, E., Horton, H., Roederer, M. and De Rosa, S. C., The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression. J. Leukoc. Biol. 2009. 85: 88-97.
44. Liu, K., Catalfamo, M., Li, Y., Henkart, P. A. and Weng, N. P., IL-15 mimics T cell receptor crosslinking in the induction of cellular proliferation, gene expression, and cytotoxicity in CD8+ memory T cells. Proc. Natl. Acad. Sci. USA 2002. 99: 6192-6197.
45. Deshpande, P., Cavanagh, M. M., Le Saux, S., Singh, K., Weyand, C. M. and Goronzy, J. J., IL-7- and IL-15-mediated TCR sensitization enables T cell responses to self-antigens. J. Immunol. 2013. 190: 1416-1423.
46. Tupin, E., Kinjo, Y. and Kronenberg, M., The unique role of natural killer T cells in the response to microorganisms. Nat. Rev. Microbiol. 2007. 5: 405-417.
47. Cho, Y. N., Kee, S. J., Kim, T. J., Jin, H. M., Kim, M. J., Jung, H. J., Park, K. J. et al., Mucosal-associated invariant T cell deficiency in systemic lupus erythematosus. J. Immunol. 2014. 193: 3891-3901.
48. Kirman, I. and Nielsen, O. H., Increased numbers of interleukin-15-expressing cells in active ulcerative colitis. Am. J. Gastroenterol. 1996. 91: 1789-1794.
49. Sakai, T., Kusugami, K., Nishimura, H., Ando, T., Yamaguchi, T., Ohsuga, M., Ina, K. et al., Interleukin 15 activity in the rectal mucosa of inflammatory bowel disease. Gastroenterology 1998. 114: 1237-1243.
50. Liu, Z., Geboes, K., Colpaert, S., D'Haens, G. R., Rutgeerts, P. and Ceuppens, J. L., IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production. J. Immunol. 2000. 164: 3608-3615.
51. Kanai, T., Watanabe, M., Okazawa, A., Nakamaru, K., Okamoto, M., Naganuma, M., Ishii, H. et al., Interleukin 18 is a potent proliferative factor for intestinal mucosal lymphocytes in Crohn's disease. Gastroenterology 2000. 119: 1514-1523.
52. Ziolkowska, M., Koc, A., Luszczykiewicz, G., Ksiezopolska-Pietrzak, K., Klimczak, E., Chwalinska-Sadowska, H. and Maslinski, W., High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J. Immunol. 2000. 164: 2832-2838.
53. Gracie, J. A., Forsey, R. J., Chan, W. L., Gilmour, A., Leung, B. P., Greer, M. R., Kennedy, K. et al., A proinflammatory role for IL-18 in rheumatoid arthritis. J. Clin. Invest. 1999. 104: 1393-1401.
54. Thurkow, E. W., van der Heijden, I. M., Breedveld, F. C., Smeets, T. J., Daha, M. R., Kluin, P. M., Meinders, A. E. et al., Increased expression of IL-15 in the synovium of patients with rheumatoid arthritis compared with patients with Yersinia-induced arthritis and osteoarthritis. J. Pathol. 1997. 181: 444-450.
55. Petrovic-Rackov, L. and Pejnovic, N., Clinical significance of IL-18, IL-15, IL-12 and TNF-alpha measurement in rheumatoid arthritis. Clin. Rheumatol. 2006. 25: 448-452.
56. Di Sabatino, A., Ciccocioppo, R., Cupelli, F., Cinque, B., Millimaggi, D., Clarkson, M. M., Paulli, M. et al., Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut 2006. 55: 469-477.
57. Furuya, D., Yagihashi, A., Komatsu, M., Masashi, N., Tsuji, N., Kobayashi, D. and Watanabe, N., Serum interleukin-18 concentrations in patients with inflammatory bowel disease. J. Immunother. 2002. 25 (Suppl 1): S65-S67.
58. Kimura, A., Ono, S., Hiraki, S., Takahata, R., Tsujimoto, H., Miyazaki, H., Kinoshita, M. et al., The postoperative serum interleukin-15 concentration correlates with organ dysfunction and the prognosis of septic patients following emergency gastrointestinal surgery. J. Surg. Res. 2012. 175: e83-e88.
59. van de Veerdonk, F. L., Wever, P. C., Hermans, M. H., Fijnheer, R., Joosten, L. A., van der Meer, J. W., Netea, M. G. et al., IL-18 serum concentration is markedly elevated in acute EBV infection and can serve as a marker for disease severity. J. Infect. Dis. 2012. 206: 197-201.
60. Ueda, T., Takeyama, Y., Yasuda, T., Matsumura, N., Sawa, H., Nakajima, T., Ajiki, T. et al., Significant elevation of serum interleukin-18 levels in patients with acute pancreatitis. J. Gastroenterol. 2006. 41: 158-165.
61. Livak, K. J. and Schmittgen, T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001. 25: 402-408.